title: Bevacizumab alone or in combination with chemotherapy in glioblastomas?
authors.affiliation: Ellis Fischel Cancer Center, University of Missouri Columbia, Missouri, MO 65212, USA. Electronic address: razash@health.missouri.edu.
authors.forename: Shahzad
authors.initials: S
authors.lastname: Raza
authors.affiliation: Ellis Fischel Cancer Center, University of Missouri Columbia, Missouri, MO 65212, USA.
authors.forename: Belal
authors.initials: B
authors.lastname: Firwana
authors.affiliation: Ellis Fischel Cancer Center, University of Missouri Columbia, Missouri, MO 65212, USA.
authors.forename: Donald C
authors.initials: DC
authors.lastname: Doll
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D001932:Brain Neoplasms / Q000628:therapy*; D005260:Female; D005909:Glioblastoma / Q000628:therapy*; D006801:Humans; D008130:Lomustine / Q000008:administration & dosage*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000401:mortality*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D008130:Lomustine